Literature DB >> 12019920

Cytokine production in patients with tuberculous pericarditis.

L J Burgess1, H Reuter, M E Carstens, J J F Taljaard, A F Doubell.   

Abstract

SETTING: An academic hospital in the Western Cape, South Africa.
OBJECTIVE: To evaluate cytokine production (interferon-gamma [IFN-gamma], interleukin-1 [IL-1], interleukin-2 [IL-2], interleukin-6 [IL-6], interleukin-10 [IL-10], interleukin-4 [IL-4] and tumour necrosis factor-alpha [TNF-alpha]) in patients with tuberculous pericarditis.
DESIGN: Subpopulation of a consecutive prospective case series. PATIENTS: Thirty patients presenting with pericardial effusions due to tuberculosis (n = 19), malignancy (n = 6) and non-tuberculous infections (n = 5), and five control subjects who had undergone open heart surgery.
RESULTS: The concentration of IFN-gamma was significantly higher in tuberculous pericardial effusions than in the other diagnostic classes (P < 0.0005). The concentration of TNF-alpha was similar in both infective and tuberculous effusions, but was significantly higher than that of malignant effusions. IL-1 and IL-2 were undetectable in malignant effusions, but elevated in both infective and tuberculous pericardial effusions. The levels of IL-1 and IL-2 were furthermore significantly higher in pericardial effusions due to infective compared to tuberculous causes. The concentration of IL-6, while elevated in all diagnostic classes, was significantly higher in the malignant group. Elevated levels of IL-10 and undetectable levels of IL-4 were observed in all three diagnostic groups.
CONCLUSION: These findings suggest that tuberculous pericardial effusions arise due to a hypersensitivity reaction that is orchestrated by the TH-1 lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019920

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Authors:  Kerryn Matthews; Armin Deffur; Mpiko Ntsekhe; Faisal Syed; James B W Russell; Kemi Tibazarwa; Janine Wolske; Johan Brink; Bongani M Mayosi; Robert J Wilkinson; Katalin A Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

Review 2.  Heart failure in children in tropical regions.

Authors:  Manojkumar Rohit; Ankur Gupta; K K Talwar
Journal:  Curr Heart Fail Rep       Date:  2013-12

3.  Lactate determination in pleural and abdominal effusions: a quick diagnostic marker of exudate-a pilot study.

Authors:  Giovanni Porta; Fabio G Numis; Valerio Rosato; Antonio Pagano; Mario Masarone; Giorgio Bosso; Claudia Serra; Luca Rinaldi; Maria C Fascione; Annalisa Amelia; Fiorella Paladino; Fernando Schiraldi
Journal:  Intern Emerg Med       Date:  2017-09-30       Impact factor: 3.397

4.  Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis.

Authors:  Arsen D Ristić; Sabine Pankuweit; Ružica Maksimović; Rainer Moosdorf; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

5.  Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis.

Authors:  Chao Liu; Yun-Liang Cui; Chun-Mei Ding; Yan-Hua Wu; Hui-Li Li; Xiao-Fei Liu; Zhi-De Hu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

6.  Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.

Authors:  Kerryn Matthews; Katalin A Wilkinson; Barbara Kalsdorf; Teri Roberts; Andreas Diacon; Gerhard Walzl; Janine Wolske; Mpiko Ntsekhe; Faisal Syed; James Russell; Bongani M Mayosi; Rodney Dawson; Keertan Dheda; Robert J Wilkinson; Willem A Hanekom; Thomas J Scriba
Journal:  Tuberculosis (Edinb)       Date:  2011-07-20       Impact factor: 3.131

7.  Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.

Authors:  Mpiko Ntsekhe; Kerryn Matthews; Faisal F Syed; Armin Deffur; Motasim Badri; Patrick J Commerford; Bernard J Gersh; Katalin A Wilkinson; Robert J Wilkinson; Bongani M Mayosi
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

8.  CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis.

Authors:  Gal Markel; Massimo Imazio; Nira Koren-Morag; Gilli Galore-Haskel; Jacob Schachter; Michal Besser; Davide Cumetti; Silvia Maestroni; Arie Altman; Yehuda Shoenfeld; Antonio Brucato; Yehuda Adler
Journal:  Oncotarget       Date:  2016-04-05

9.  Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

Authors:  Thomas J Scriba; Adam Penn-Nicholson; Smitha Shankar; Tom Hraha; Ethan G Thompson; David Sterling; Elisa Nemes; Fatoumatta Darboe; Sara Suliman; Lynn M Amon; Hassan Mahomed; Mzwandile Erasmus; Wendy Whatney; John L Johnson; W Henry Boom; Mark Hatherill; Joe Valvo; Mary Ann De Groote; Urs A Ochsner; Alan Aderem; Willem A Hanekom; Daniel E Zak
Journal:  PLoS Pathog       Date:  2017-11-16       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.